CTA
LOXO

Carillon Tower Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

Carillon Tower Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-256,146
Closed -$35.9M – 484
2018
Q4 		$35.9M Hold
256,146
– – 0.3% 118
2018
Q3 		$43.8M Buy
+256,146
New +$43M 0.31% 122

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Carillon Tower Advisers's LOXO Position: Q1 2019 in Review

Carillon Tower Advisers sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 256,146 shares — an estimated $35.9M sold.

Carillon Tower Advisers first reported a position in LOXO in Q3 2018 and held it in 2 quarters. The position peaked at $43.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Carillon Tower Advisers reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 256,146 Loxo Oncology, Inc shares in Q1 2019, an estimated $35.9M.
  • Carillon Tower Advisers first reported a position in Loxo Oncology, Inc in Q3 2018 and held it in 2 quarters.
  • Carillon Tower Advisers's Loxo Oncology, Inc position peaked at $43.8M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Carillon Tower Advisers's 13F filing for Q1 2019, filed 3 May 2019.